Cognizant Technology Solutions (CTSH) is up 5.9% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be a bullish analyst upgrade tied to stronger confidence in Cognizant’s AI strategy and its ability to turn large client contracts into revenue later in 2026. Recent partnership announcements and solid first-quarter results likely added support to the move by reinforcing the idea that demand for the company’s AI and modernization services is improving.
Details:
Wedbush recently upgraded Cognizant to Outperform from Neutral and raised its price target, citing expected momentum in the company’s AI strategy and a path for larger deals to convert into revenue in the second half of 2026.Cognizant’s first-quarter 2026 results showed revenue growth, adjusted EPS of $1.40, and trailing 12-month bookings of $29.6 billion, which management highlighted as a record level.The company kept its full-year 2026 constant-currency revenue growth outlook at 4.0% to 6.5%, suggesting management still sees steady demand despite a mixed macro backdrop.Cognizant also announced a new partnership with Domyn to deliver sovereign AI solutions across EMEA, adding to the market’s view that the company is expanding its AI-related offerings in regulated industries.Sources:
Investing.com, Cognizant, StockTitan
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CTSH Insider Trading Activity
$CTSH insiders have traded $CTSH stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:
- MICHAEL PATSALOS-FOX sold 2,000 shares for an estimated $168,460
- SURYA GUMMADI (President - Americas) sold 1,728 shares for an estimated $143,523
- ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 6 sales selling 895 shares for an estimated $47,817.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Quiver Alerts
Receive CTSH Data Alerts
Get market-moving data, filings, and signals for CTSH in real time.
Sign Up
$CTSH Hedge Fund Activity
We have seen 407 institutional investors add shares of $CTSH stock to their portfolio, and 505 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MORGAN STANLEY added 5,806,173 shares (+77.8%) to their portfolio in Q1 2026, for an estimated $356,208,713
- NOMURA HOLDINGS INC added 4,488,800 shares (+331.8%) to their portfolio in Q1 2026, for an estimated $275,387,880
- CITADEL ADVISORS LLC removed 3,697,601 shares (-51.8%) from their portfolio in Q1 2026, for an estimated $226,847,821
- NATIONAL BANK OF CANADA /FI/ removed 3,336,295 shares (-57.8%) from their portfolio in Q1 2026, for an estimated $204,681,698
- CAPITAL RESEARCH GLOBAL INVESTORS added 3,154,556 shares (+49.6%) to their portfolio in Q1 2026, for an estimated $193,532,010
- FMR LLC removed 2,866,441 shares (-80.0%) from their portfolio in Q1 2026, for an estimated $175,856,155
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 2,708,542 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $166,169,051
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CTSH Congressional Stock Trading
Members of Congress have traded $CTSH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$CTSH Analyst Ratings
Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Susquehanna issued a "Positive" rating on 05/01/2026
- Guggenheim issued a "Buy" rating on 04/30/2026
- Wells Fargo issued a "Overweight" rating on 04/30/2026
To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.
$CTSH Price Targets
Multiple analysts have issued price targets for $CTSH recently. We have seen 15 analysts offer price targets for $CTSH in the last 6 months, with a median target of $71.0.
Here are some recent targets:
- Bryan Bergin from TD Cowen set a target price of $47.0 on 06/26/2026
- James Faucette from Morgan Stanley set a target price of $44.0 on 06/23/2026
- Bryan Keane from Citigroup set a target price of $55.0 on 06/09/2026
- Steven Wahrhaftig from Wedbush set a target price of $70.0 on 06/08/2026
- Arvind Ramnani from Truist Securities set a target price of $66.0 on 06/01/2026
- Dan Dolev from Mizuho set a target price of $68.0 on 05/06/2026
- James Friedman from Susquehanna set a target price of $88.0 on 05/01/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »
View the Zacks #1 Rank List
Cognizant Rallies as Analyst Upgrade and AI Momentum Lift Sentiment
Cognizant Technology Solutions (CTSH) is up 5.9% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be a bullish analyst upgrade tied to stronger confidence in Cognizant’s AI strategy and its ability to turn large client contracts into revenue later in 2026. Recent partnership announcements and solid first-quarter results likely added support to the move by reinforcing the idea that demand for the company’s AI and modernization services is improving.
Details:
Sources:
Investing.com, Cognizant, StockTitan
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CTSH Insider Trading Activity
$CTSH insiders have traded $CTSH stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CTSH Hedge Fund Activity
We have seen 407 institutional investors add shares of $CTSH stock to their portfolio, and 505 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CTSH Congressional Stock Trading
Members of Congress have traded $CTSH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$CTSH Analyst Ratings
Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.
$CTSH Price Targets
Multiple analysts have issued price targets for $CTSH recently. We have seen 15 analysts offer price targets for $CTSH in the last 6 months, with a median target of $71.0.
Here are some recent targets:
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Read full article here »